Evoke Pharma Inc (EVOK NASDAQ) stock market data APIs
$2.6492
-0.03(-1.1%)
as of July 1, 2025
Try our APIs with
free plan!
Evoke Pharma Inc Financial Data Overview
Price chart is built with
Anychart
Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, California.
Prev. Close
2.6492
Open
2.6189
High
2.6492
Low
2.6189
52 wk Range
1.94-7.2
Market Cap
3 881 K
Shares Outstanding
1 493 K
Revenue
11 594 K
EPS
-0.51
Beta
0.025
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evoke Pharma Inc data using free add-ons & libraries
Get Evoke Pharma Inc Fundamental Data
Evoke Pharma Inc Fundamental data includes:
- Net Revenue: 11 594 K
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.33
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evoke Pharma Inc News
New
evoke director Andrea Gisle Joosen to join Atlantic Grupa board
LONDON - Evoke plc announced Thursday that Andrea Gisle Joosen, Independent Non-Executive Director at the company, will be appointed as a member of the Supervisory Board of Atlantic Grupa d.d., effect...
Andrea Gisle Joosen appointed to Grafton Group board
LONDON - Evoke PLC announced Wednesday that Andrea Gisle Joosen, an Independent Non-Executive Director at the company, has been appointed as Non-Executive Director of Grafton Group plc, effective July...
Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
Q1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use SOLANA BEACH, Calif., May 13, 2025 (GLOBE NEW...
Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025
SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders with an empha...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
